Targeted gene sequencing panel resolves unexplained cholestasis in about 5% of adults

A targeted next generation sequencing gene panel could offer a definitive diagnosis for some adults with unexplained cholestasis.

AASLD 2025 Reflections: Key takeaways in late-onset genetic cholestasis

Dr Silvia Vilarinho and Dr Deepak Joshi share the highlights from AASLD The Liver Meeting 2025, with an emphasis on late-onset genetic cholestasis, and offer quick insights into new data on the growing utility of genetic testing and expanding therapeutic implications.

Contraceptives linked to unique cholestatic phenotype

Raj Vuppalanchi reports findings characterizing the phenotype of women with hormonal contraceptive-associated drug-induced liver injury.